SINO BIOPHARMACEUTICAL
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemical medicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
SINO BIOPHARMACEUTICAL
Industry:
Biotechnology Health Care Health Diagnostics Hospital Medical Pharmaceutical
Founded:
1997-02-02
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Nginx Euro Google Apps For Business Pound Sterling Japanese Yen Java EE Network Solutions DNS Unsplash
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Fatigue Science Institute
Fatigue Science is a research, development and sales of medical technology and medical supplies for various diseases, and treatment.
Kanzawa Medical Research Foundation
Kanzawa Medical Research Foundation promotes the development of healthcare and medical science by encouraging studies.
Samjin Pharmaceutical
Samjin Pharmaceutical is a company that pioneeres a healthy life for human beings with a creative mind and advances for a prosperous future.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-23 | Softhale | Softhale acquired by Sino Biopharmaceutical | 110 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Generon (Shanghai) Corporation | Sino Biopharmaceutical investment in Venture Round - Generon (Shanghai) Corporation | 70 M USD |
| 2021-12-12 | Medlinker | Sino Biopharmaceutical investment in Series E - Medlinker | 514 M USD |
| 2021-11-18 | Treadwell Therapeutics | Sino Biopharmaceutical investment in Series B - Treadwell Therapeutics | 91 M USD |
| 2021-08-11 | XtalPi | Sino Biopharmaceutical investment in Series D - XtalPi | 400 M USD |
| 2020-12-06 | Sinovac Life Sciences | Sino Biopharmaceutical investment in Corporate Round - Sinovac Life Sciences | 500 M USD |
| 2019-11-04 | Akeso Biopharma | Sino Biopharmaceutical investment in Series D - Akeso Biopharma | 150 M USD |
| 2015-08-05 | LifeBond | Sino Biopharmaceutical investment in Series D - LifeBond | 27 M USD |
More informations about "Sino Biopharmaceutical" on Search Engine
Sino Biopharm
Led by Mr. Tse, CP Pharmaceutical Group now has developed to a large integrated life and healthcare enterprise, and its Hong Kong listed flagship Sino Biopharmaceutical …See details»
Sino Biopharmaceutical Limited - Wikipedia
Sino Biopharmaceutical Limited (SEHK: 1177|Hang Seng Index component) (simplified Chinese: 中国生物制药有限公司; traditional Chinese: 中國生物製藥有限公司; pinyin: zhōng guó shēng wù zhì yào yǒu xiàn gōng sī), shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China. Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino …See details»
How the Sinopharm Covid-19 Vaccine Works - The …
Dec 30, 2020 How the Sinopharm Covid-19 Vaccine Works - The New York Times. How the Sinopharm Vaccine Works. By Jonathan Corum …See details»
Sino Biopharm and Boehringer Ingelheim enter into strategic ...
Apr 8, 2024 Sino Biopharmaceutical Limited, or Sino Biopharm, a China-based Hang Seng Index company, and Boehringer Ingelheim, a global biopharmaceutical company, …See details»
Sino Biopharm and Boehringer Ingelheim enter into strategic ...
Apr 9, 2024 Sino Biopharmaceutical Limited, or Sino Biopharm, a China-based Hang Seng Index company, and Boehringer Ingelheim, a global biopharmaceutical company, …See details»
Sino Biopharm profit surges 427.2% year-on-year
Apr 16, 2024 Sino Biopharmaceutical Limited, or Sino Biopharm, a leading innovative research and development-driven pharmaceutical conglomerate in China, announced in its annual result report released …See details»
Sino Biopharm shows stable growth in 2023 - Chinadaily.com.cn
Apr 2, 2024 Sino Biopharmaceutical Limited, or Sino Biopharm, a leading innovative research and development-driven pharmaceutical conglomerate in China, announced on …See details»
Sino Biopharm profit surges 427.2% year-on-year
Apr 1, 2022 Sino Biopharmaceutical Limited, or Sino Biopharm, a leading innovative research and development-driven pharmaceutical conglomerate in China, announced in …See details»
Sino Biopharm, Boehringer partner on oncology assets in China
April 8, 2024. By Tamra Sami. Sino Biopharmaceutical Ltd. and Boehringer Ingelheim International GmbH are partnering to develop innovative cancer therapies in mainland …See details»
Sino Biopharm continues global growth - Chinadaily.com.cn
4 days ago China's pharmaceutical conglomerate Sino Biopharmaceutical Limited, or Sino Biopharm, announced on Thursday the acquisition of Nasdaq-listed United …See details»
Sino Biopharmaceutical : 2023 ENVIRONMENTAL, SOCIAL AND …
9 hours ago It aims to fully and truly present the management practice and performance of Sino Biopharmaceutical Limited in the ESG aspects in 2023 to its major stakeholders …See details»
Sino Biopharmaceutical - Crunchbase Investor Profile & Investments
Legal Name Sino Biopharmaceutical Ltd. Number of Exits. 2. Stock Symbol HKG:1177. Company Type For Profit. Phone Number +852 2802 9886. Sino Biopharmaceutical …See details»
Sinopharm Group - Wikipedia
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state …See details»
Sino Biopharmaceutical plans 2 acquisitions to increase stake in ...
Jan 8, 2018 Sino Biopharmaceutical Ltd. agreed to fully acquire two of its partially-owned investment holding companies to increase its stake in Beijing Tide Pharmaceutical Co. …See details»
Sino Biopharm
© 2023 Sino Biopharmaceutical Co., Ltd. All rights reserved. Friendly link invoX Pharma Limited CTTQ Pharmaceutical Tide Pharmaceutical CP Group CTTQ Pharmaceutical ...See details»
Sino Biopharm
Executive Director and Chairwoman. is the chairwoman of the Board, an executive director, and the chairwoman of the executive board committee and the nomination committee of …See details»
Sino Biopharmaceutical - Investments, Portfolio & Company Exits
About. Sino Biopharmaceutical has made 7 investments. Their most recent investment was on Jun 2, 2022, when Generon (Shanghai) Corporation raised. $70M. Sino …See details»
Sino Biopharmaceutical - Contacts, Employees, Board Members, …
Sino Biopharmaceutical is a pharmaceutical company that engages in research, development and pharmaceutical products for treating diseases.See details»
Sino Biopharm
On the morning of August 24, Sino Biopharm (HK.01177) held its 2022 interim results conference and the first Investor Day in Beijing. The company's Chairwoman of the …See details»
Sino Biopharm secures room for future growth with US$515 …
Dec 7, 2020 Sino Biopharmaceutical on Monday announced a US$515 million investment in Covid-19 vaccine developer Sinovac Life Sciences, as the Beijing-based …See details»